The New York Times Agency May 2010

EN_00913897_2723

caption

(NYT25) NEW YORK -- Aug. 12, 2002 -- IMCLONE-WAKSAL -- Samuel D. Waksal, center, the founder and former chief executive of ImClone, arrived Monday at the federal courthouse in Manhattan. He was arrested on June 12 in a federal insider-trading investigation. Waksal, pleaded not guilty to charges that he had tipped off relatives about the rejection of the company's cancer drug, Erbitux, leading to $10 million in stock sales by Waksal family members. (Justin Lane/The New York Times)*LITE*, *STANDALONE PHOTO*

special instructions

CENA MINIMALNA - 100 USD

headline The New York Times Agency May 2010

created date 2002-08-12

credit EAST NEWS

source The New York Times Agency

byline Justin Lane/The New York Times/Redux

original transmission reference 17339311

weight 0,33MB

size 14cm x 8cm przy 300dpi

keywords - Pokaż

10, 12, 2002, A, ABOUT, AND, ARRESTED, ARRIVED, AT, AUG, BY, CANCER, CENTER, CHARGES, CHIEF, COMPANY, COURTHOUSE, DRUG, ERBITUX, EXECUTIVE, FAMILY, FEDERAL, FORMER, FOUNDER, GUILTY, HAD, HE, IMCLONE, IMCLONE-WAKSAL, IN, INSIDER-TRADING, INVESTIGATION, JUNE, JUSTIN, LANE, LEADING, LITE, MANHATTAN, MEMBERS, MILLION, MONDAY, NEW, NOT, NYT25, OF, OFF, ON, PLEADED, REDUX, REJECTION, RELATIVES, SAMUEL, STANDALONE, STOCK, THAT, THE, TIMES, TIPPED, TO, WAKSAL, WAS, YORK,